BlackRock Institutional Trust’s Ocular Therapeutix OCUL Stock Holding History

BlackRock Institutional Trust’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.49M	Buy	536,703 +100,840	+23%	+$782K	﹤0.01%	2770
2016 Q3	$2.99M	Buy	435,863 +141,255	+48%	+$861K	﹤0.01%	2901
2016 Q2	$1.46M	Buy	294,608 +32,748	+13%	+$324K	﹤0.01%	3172
2016 Q1	$2.53M	Sell	261,860 -3,652	-1%	-$27.7K	﹤0.01%	2952
2015 Q4	$2.49M	Buy	265,512 +4,690	+2%	+$50.6K	﹤0.01%	3027
2015 Q3	$3.67M	Buy	260,822 +82,626	+46%	+$1.66M	﹤0.01%	2855
2015 Q2	$3.75M	Buy	178,196 +108,721	+156%	+$2.69M	﹤0.01%	2869
2015 Q1	$2.92M	Buy	69,475 +23,986	+53%	+$789K	﹤0.01%	2953
2014 Q4	$1.07M	Sell	45,489 -34,894	-43%	-$587K	﹤0.01%	3337
2014 Q3	$1.2M	Buy	+80,383	New	+$1.19M	﹤0.01%	3252

Other funds holding OCUL

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's OCUL Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Ocular Therapeutix (OCUL) stake by 23% in Q4 2016, buying an estimated $782K and bringing the position to 536,703 shares worth $4.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

BlackRock Institutional Trust first reported a position in OCUL in Q3 2014 and has held it in 10 quarters since. 76 funds tracked by Wall St. Rank hold OCUL as of Q4 2016.

BlackRock Institutional Trust held 536,703 shares of Ocular Therapeutix worth $4.49M as of Q4 2016.
BlackRock Institutional Trust bought 100,840 Ocular Therapeutix shares in Q4 2016, an estimated $782K.
Ocular Therapeutix made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2770 holding.
BlackRock Institutional Trust first reported a position in Ocular Therapeutix in Q3 2014 and has held it in 10 quarters since.
76 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.